clinical trial · NCT02249442
Study to Determine the Pharmacokinetics on TPV/r in Subjects With Mild and Moderate Hepatic Insufficiency
Boehringer Ingelheim·phase1·completed·n = 24
Hepatic InsufficiencyTipranavir (TPV)Ritonavir (r)
brief summary
To determine the pharmacokinetics of single-dose and steady-state Tipranavir/Ritonavir (TPV/r) 500/200 mg in subjects with mild to moderate hepatic insufficiency
started
Oct 1, 2003
primary completion
Jun 1, 2004
completion
—
last updated
Jan 23, 2025
official title
An Open-label Study to Determine the Pharmacokinetics of Single-dose and/or Steady-state TPV/r 500/200 mg in Subjects With Mild and Moderate Hepatic Insufficiency
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol